A Study to Evaluate the Food Effect on the Pharmacokinetics of RNK08954 Tablets and to Assess the Mass Balance of [14C]RNK08954 in Healthy Adult Male Subjects in China
Latest Information Update: 21 Jan 2026
At a glance
- Drugs RNK 08954 (Primary)
- Indications Adenocarcinoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Ranok Therapeutics
Most Recent Events
- 21 Jan 2026 New trial record